#USA #Elanco Animal Health #Chief Financial Officer #Robert VanHimbergen #Greenfield, Indiana

Elanco Animal Health Welcomes New Leadership

Elanco Animal Health Incorporated, a prominent name in the animal health sector, recently announced a significant addition to its leadership team. Effective July 7, 2025, Robert (Bob) VanHimbergen will take on the role of Chief Financial Officer (CFO) and Executive Vice President. This appointment comes following an extensive search process and marks a pivotal moment for Elanco as it continues its commitment to long-term growth and value creation.

Transition and Leadership Background

VanHimbergen's previous experience includes his role as the Senior Vice President and CFO at Hillenbrand, Inc., where he played a crucial role in transforming the firm into a focused industrial business. With nearly three decades of financial leadership, he has a proven track record, having spent 15 years at Johnson Controls in various high-level financial roles, including overseeing their global finance and accounting functions. His significant experience spans multiple continents, adding an international perspective to Elanco’s leadership.

Todd Young, the outgoing CFO, will assist in ensuring a smooth transition for VanHimbergen until August 31, 2025. Young has been instrumental in establishing Elanco as an independent company and diversifying its offerings through strategic acquisitions. His leadership and insight will be invaluable in helping VanHimbergen settle into his new role.

Fostering Growth and Innovation

Jeff Simmons, President and CEO of Elanco, expressed enthusiasm for VanHimbergen joining the executive committee, highlighting that his experience and approach to leadership align perfectly with Elanco’s goals. Simmons noted that Elanco has experienced seven consecutive quarters of growth and possesses a portfolio of promising products nearing launch. The company aims to maintain this momentum and is focused on enhancing innovation, expanding global presence, and improving profit margins while generating cash.

VanHimbergen stated, “I am thrilled to join Elanco at this exciting time with the company's momentum and diverse portfolio of innovation.” His focus will be on executing company strategies, boosting growth, and enhancing shareholder value, which remains a top priority.

Elanco's Commitment to Animal Health

Elanco prides itself on being a leader in animal health, dedicated to developing products and services that prevent and treat diseases in both farm animals and pets. The company has a rich history spanning over 70 years, continually evolving to meet the needs of farmers, pet owners, and veterinarians. This commitment is underpinned by Elanco’s vision of improving life through food and companionship while making a meaningful impact in the communities it operates.

As the company prepares for its next stage of growth, the leadership transition is poised to reinforce Elanco’s position in the market, enabling it to respond to the demands of an evolving industry landscape. VanHimbergen's appointment is seen as a strategic move to build on Elanco’s recent successes and bolster future initiatives, enhancing the vital role the company plays in animal wellness and health.

In the coming months, Elanco will continue to implement its strategies that focus on innovation, global expansion, and the creation of sustainable value. The company has also reiterated its guidance for the second quarter and full year during its recent earnings call, reaffirming its commitment to transparency and accountability with its stakeholders.

With a clear direction and an experienced leader at the helm of its financial strategies, Elanco is well-positioned to capitalize on the opportunities within the animal health market, ensuring continued growth and innovation as it strives for excellence.